GlassScriptPhysician profile
Paul Drucker
NPI 1316162985
$26,510.26
in general payments reported to CMS, 2019-2025
13 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2021: $23.45 · 2022: $322 · 2023: $227 · 2024: $474 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990 · Travel and Lodging: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.99 |
| Travel and Lodging | $198.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $24,730.22 | 2019 | |
| Amgen INC. | $332.85 | 2024-2025 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $198.21 | 2023 | |
| Bioventus LLC | $184.74 | 2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $180.00 | 2022 | |
| Stryker Corporation | $172.41 | 2025 | Prostep Mica, Variax, Gravity |
| Horizon Therapeutics Plc | $153.45 | 2019 | |
| Treace Medical Concepts, INC. | $138.77 | 2024 | |
| Globus Medical, INC. | $132.31 | 2025 | Senza |
| Organogenesis INC. | $125.00 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $93.15 | 2019 | |
| Paratek Pharmaceuticals, INC. | $40.24 | 2021-2022 | |
| Medtronic, INC. | $28.91 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Drucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.